1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
Real-time Euronext Amsterdam  -  05/16 05:49:23 am EDT
23.42 EUR   -0.02%
05:01aPhilips showcases ultra-low contrast PCI solutions at EuroPCR 2022
GL
05:00aPhilips showcases ultra-low contrast PCI solutions at EuroPCR 2022
AQ
04:01aNew release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S. FDA classifies Philips ventilator recall as most serious

01/26/2022 | 02:30pm EDT

Jan 26 (Reuters) - The U.S. Food and Drug Administration (FDA) on Wednesday classified medical equipment maker Philips' recall of certain new ventilators in December as "class 1", or the most serious type of recall.

The company recalled the Trilogy Evo ventilators in December due to potential health risks from a type of foam used in the devices. (Reporting by Amruta Khandekar; Editing by Devika Syamnath)


ę Reuters 2022
All news about PHILIPS NV
05:01aPhilips showcases ultra-low contrast PCI solutions at EuroPCR 2022
GL
05:00aPhilips showcases ultra-low contrast PCI solutions at EuroPCR 2022
AQ
04:01aNew release of Philips EchoNavigator helps interventional teams treat structural heart ..
GL
05/12PHILIPS NV : Ex-dividend day for final dividend (optional)
FA
05/10Shareholders Vote Down Philips' Executive Compensation Plan
MT
05/10Philips Annual General Meeting of Shareholders approves dividend and other proposals ma..
GL
05/10Royal Philips Approves Appointment of Mrs. Herna Verhagen and Mr. Sanjay Poonen as Memb..
CI
05/10Royal Philips Approves Dividend for the Year 2021
CI
05/10TRANSCRIPT : Koninklijke Philips N.V. - Shareholder/Analyst Call
CI
05/09SECTOR UPDATE : Health Care Stocks Decline Premarket Monday
MT
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2022 18 269 M 19 016 M 19 016 M
Net income 2022 795 M 827 M 827 M
Net Debt 2022 4 113 M 4 281 M 4 281 M
P/E ratio 2022 23,7x
Yield 2022 3,72%
Capitalization 20 359 M 21 192 M 21 192 M
EV / Sales 2022 1,34x
EV / Sales 2023 1,25x
Nbr of Employees 78 189
Free-Float 97,5%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 23,42 €
Average target price 32,18 €
Spread / Average Target 37,4%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-28.52%21 192
THERMO FISHER SCIENTIFIC-18.86%211 945
DANAHER CORPORATION-24.26%178 394
INTUITIVE SURGICAL, INC.-37.74%80 295
SIEMENS HEALTHINEERS AG-17.38%63 485
EDWARDS LIFESCIENCES CORPORATION-24.70%60 652